Back to Search
ELLIE THOMAS, PHARMD
PHARMD
Pharmacist
NPI: 1750978953Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
2018026774(MO)
Research & Publications (20)
Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors.
PMID 19396637·Mol Neurobiol·2009
6-review
Osteoporotic fracture of the sacrum: sacroplasty and physical medecine.
PMID 19515622·Ann Phys Rehabil Med·2009
5-case
Neonatal intrahepatocellular lipid.
PMID 18723779·Arch Dis Child Fetal Neonatal Ed·2008
4-observational
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
PMID 18829438·Proc Natl Acad Sci U S A·2008
7-preclinical
Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D.
PMID 17011169·Schizophr Res·2007
7-preclinical
Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.
PMID 17220533·Mol Neurobiol·2006
6-review
Striatal specificity of gene expression dysregulation in Huntington's disease.
PMID 16983659·J Neurosci Res·2006
6-review
A National Survey of ICU consultant working practices at weekends.
PMID 15488053·Anaesthesia·2004
8-other
Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype.
PMID 12873803·Biol Psychiatry·2003
8-other
Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins.
PMID 14647396·Mol Psychiatry·2003
7-preclinical
Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders.
PMID 14623496·Prostaglandins Leukot Essent Fatty Acids·2003
7-preclinical
Efficacy of transforaminal versus interspinous corticosteroid injectionin discal radiculalgia - a prospective, randomised, double-blind study.
PMID 14579160·Clin Rheumatol·2003
3-trial
From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders.
PMID 12942994·Curr Mol Med·2003
6-review
Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
PMID 12610649·Mol Psychiatry·2003
8-other
Metastatic pudendal nerve compression presenting as atypical sciatica.
PMID 12177550·J Spinal Disord Tech·2002
5-case
A neural network model of sensitization of evoked cortical responses in migraine.
PMID 11993613·Cephalalgia·2002
8-other
Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice.
PMID 11739619·J Neurochem·2001
7-preclinical
Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration.
PMID 11514062·Neurosci Lett·2001
7-preclinical
Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.
PMID 11274430·Proc Natl Acad Sci U S A·2001
8-other
Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy.
PMID 11158250·J Neurochem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5540 N FARMER BRANCH RD
OZARK, MO 65721 - Phone
- (417) 485-8555
Quick Facts
- NPI
- 1750978953
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile